Europe - France

BCTG Avocats

More informationMore information

BCTG Avocats houses a broad team which exhibits deep bench strength across a variety of areas, including distribution strategy, patent infringement actions concerning generics, and partnership contracts. The practice is jointly led by Hugues Villey-Desmeserets, François Dauba, and Gaëlle Bloret-Pucci. Villey-Desmeserets has a great deal of knowledge spanning the drafting and negotiation of commercial contracts and competition related issues, regularly appearing before the FCC and the General Directorate for Fair Trading, Consumer Affairs and Fraud Control (DGCCRF). Bloret-Pucci is an experienced litigator, maintaining an IP and IT focused practice, while Dauba assists clients with sales policy structures and distribution digital transformations.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The team has developed an incredible appetite for business issues, which allows them to perfectly understand the problems of their clients and advise them.’

  • ‘François Dauba benefits from real expertise in the field of pharmaceutical distribution, which he puts to use for the benefit of his clients, providing undeniable added value.’

Key clients

  • Teva Santé
  • Stada (EG Labo)
  • Johnson & Johnson Santé Beauté France
  • GenoSafe
  • NHCO Nutrition
  • Servier
  • Seqens
  • Iktos
  • EG427
  • Mailstone

Work highlights

  • Acted for Teva Santé in proceedings initiated by the DGCCRF before the Correctional Court following an alleged violation of the legal ceiling of discount on invoices, and on the so-called anti-gift law. The firm obtained an acquittal decision on all the grievances
  • Advised Servier on the framework of its international distribution strategy in Eastern Europe, Africa, South America and in the French overseas territories.
  • Advised Iktos, a French company specializing in the development of artificial intelligence solutions applied to the discovery of new treatments, on its series A financing of 15.5m euros with new investors M Ventures and Debiopharm Innovation Fund with the participation of Omnes Capital.

Practice head

The lawyer(s) leading their teams.

Hugues Villey-Desmeserets, François Dauba, Gaëlle Bloret-Pucci, Séverin Kullmann